Trial intelligence / Profile preview

Kanggan Granule versus ribavirin granule in children with influenza-like illness

ChiCTR-TRC-13003304Phase 4Completed

Sponsor
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Start
Jul 2013
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of Kanggan Granule and ribavirin in influenza-like illness (ILI) (2 arms), sponsored by First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoints: Fever clearance time and Clinical recovery time. Started Jul 2013; status: completed.

02

Drugs

Kanggan Granuleribavirin
03

Conditions

influenza-like illness (ILI)

Beyond the preview

Go deeper on ChiCTR-TRC-13003304.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-13003304.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call